← Back to Screener
Willow Lane Acquisition Corp. II Unit (WLIIU)
Price$10.35
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (4W)-1.38%
VGM Score73.20
Market Capitalization$204.31M
All Metrics
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-5.36%
10-Day Avg Trading Volume0.02M
EPS (Annual)$-0.00
ROA (Last FY)-45.45%
Cash Flow / Share (Annual)$0.00
EPS Incl Extra (Annual)$-0.00
Current Ratio (Annual)0.04x
3-Month Avg Trading Volume0.01M
52-Week High$10.49
EPS Excl Extra (Annual)$-0.00
Quick Ratio (Annual)0.00x
EPS Basic Excl Extra (Annual)$-0.00
Revenue / Share (Annual)$0.00
Year-to-Date Return1.09%
5-Day Price Return0.69%
EPS Normalized (Annual)$-0.00
Month-to-Date Return0.39%
EBITD / Share (Annual)$-0.00
Beta-0.19x
52-Week Low$9.86
mGradeB
vgmGradeB
Show chart for
Industry Peers — Blank Checks / SPACs(773)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
WLIIUWillow Lane Acquisition Corp. II Unit | — | — | B | $10.35 |
| KCAC.WSKensington Capital Acquisition Corp. VI Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 | F | A | A | $0.52 |
| WLACWillow Lane Acquisition Corp. Class A Ordinary Shares | — | C | A | $35.95 |
| CAEPCantor Equity Partners III, Inc. Class A Ordinary Shares | — | — | F | $6.90 |
| AACIUArmada Acquisition Corp. III Units | — | A | D | $10.08 |
| BACQRInflection Point Acquisition Corp. IV Right | — | D | D | $0.00 |
| BACQUInflection Point Acquisition Corp. IV Unit | — | D | D | $0.00 |
| AACIArmada Acquisition Corp. III Class A Ordinary Share | — | — | D | $9.95 |
| DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares | — | — | C | $10.08 |
| DMIIRDrugs Made In America Acquisition II Corp. Right | — | — | C | $0.08 |
| DMIIUDrugs Made In America Acquisition II Corp. Unit | — | — | C | $10.15 |
About
Willow Lane Acquisition Corp II is a special purpose acquisition company (SPAC) formed to pursue a merger or acquisition with an unspecified private business. The company seeks to identify and combine with an attractive target to create shareholder value. No business combination has been identified or agreed upon to date.